IL-17 is selectively induced by epicutaneous sensitization and mediates neutrophil recruitment to the lungs following antigen challenge

rui he,michiko k oyoshi,raif s geha
DOI: https://doi.org/10.4049/jimmunol.178.supp.b104
2007-01-01
Abstract:Abstract IL-17 producing effector CD4+ T cells (TH17) have been recently identified to be a new lineage of T helper cells, and thought to be important contributors to tissue inflammation. We here show that IL-17 is selectively induced by epicutaneous (EC) sensitization with ovalbumin (OVA) compared to intraperitoneal (i.p.) immunization. This is evidenced by increased serum IL-17 and increased IL-17 production by OVA stimulated cells from draining lymph nodes and spleen in EC sensitized mice. Significantly higher expression of IL-17 and CXCL-2 and infiltration of neutrophils was found in the BAL fluid and lungs of EC-sensitized mice compared with i.p-immunized mice following inhaled OVA challenge. Blockade of IL-17 prior to inhaled OVA challenge reduced CXCL-2 expression, airway inflammation and responsiveness to methacholine in EC sensitized mice. FITC+ dendritic cells (DCs) collected from draining lymph nodes 24 hrs after painting the skin with FITC, but not DCs from spleen, induced IL-17 secretion by TCR-OVA CD4+ T cells. This was inhibited by intradermal injection of anti- TGFβ neutralizing antibody. These results indicate that IL-17 is selectively induced by EC sensitization, in part due to the presence of TGFβ in the skin, and suggest that IL-17 might play an important role in airway hyper-reactivity and neutrophil infiltration in the lungs when skin is the initial site of antigen sensitization.
What problem does this paper attempt to address?